- Home
- PLRX vs SSYS Comparison
PLRX vs SSYS Comparison
Compare PLRX & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- SSYS
- Stock Information
- Founded
- PLRX 2015
- SSYS 1989
- Country
- PLRX United States
- SSYS United States
- Employees
- PLRX N/A
- SSYS N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- PLRX Health Care
- SSYS Technology
- Exchange
- PLRX Nasdaq
- SSYS Nasdaq
- Market Cap
- PLRX 680.3M
- SSYS 634.6M
- IPO Year
- PLRX 2020
- SSYS 1994
- Fundamental
- Price
- PLRX $11.37
- SSYS $12.45
- Analyst Decision
- PLRX Strong Buy
- SSYS Strong Buy
- Analyst Count
- PLRX 7
- SSYS 4
- Target Price
- PLRX $40.50
- SSYS $11.50
- AVG Volume (30 Days)
- PLRX 485.5K
- SSYS 668.2K
- Earning Date
- PLRX 02-26-2025
- SSYS 03-05-2025
- Dividend Yield
- PLRX N/A
- SSYS N/A
- EPS Growth
- PLRX N/A
- SSYS N/A
- EPS
- PLRX N/A
- SSYS N/A
- Revenue
- PLRX N/A
- SSYS $578,436,000.00
- Revenue This Year
- PLRX N/A
- SSYS N/A
- Revenue Next Year
- PLRX N/A
- SSYS $3.22
- P/E Ratio
- PLRX N/A
- SSYS N/A
- Revenue Growth
- PLRX N/A
- SSYS N/A
- 52 Week Low
- PLRX $10.22
- SSYS $6.05
- 52 Week High
- PLRX $18.00
- SSYS $13.98
- Technical
- Relative Strength Index (RSI)
- PLRX 44.60
- SSYS 76.57
- Support Level
- PLRX $10.35
- SSYS $9.17
- Resistance Level
- PLRX $11.07
- SSYS $9.91
- Average True Range (ATR)
- PLRX 0.61
- SSYS 0.54
- MACD
- PLRX 0.06
- SSYS 0.28
- Stochastic Oscillator
- PLRX 43.50
- SSYS 98.44
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.